Abbott (ABT) Announces Positive Clinical Results from ABSORB III trial of Naturally Dissolving Heart Stent
Tweet Send to a Friend
Abbott (NYSE: ABT) announced today positive one-year clinical results from the ABSORB III trial, which compared the safety and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE